Oncology & Cancer

COVID-19 immune response appears strong in cancer patients

(HealthDay)—The seropositivity rate among patients with cancer remains high four months after the second dose of the COVID-19 vaccine, according to a research letter published online Aug. 11 in JAMA Oncology.

Vaccination

Should you get a third dose of COVID vaccine?

They're cancer patients. Transplant recipients. People with lupus, rheumatoid arthritis, HIV/AIDS, sickle cell disease, kidney failure and Crohn's disease. Plus millions of others who have conditions or take medications that ...

Diseases, Conditions, Syndromes

States that had a grip on COVID now seeing a crush of cases

The COVID-19 surge that is sending hospitalizations to all-time highs in parts of the South is also clobbering states like Hawaii and Oregon that were once seen as pandemic success stories.

Immunology

Cancer vaccine improves outcomes in Lynch syndrome model

A new strategy for developing vaccines against cancer showed promise in a proof-of-concept study led by scientists at Weill Cornell Medicine, NewYork-Presbyterian and Heidelberg University Hospital.

page 22 from 40